Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M559Revenue $M191Net Margin (%)-20.7Altman Z-Score0.6
Enterprise Value $M736EPS $-1.4Operating Margin %-10.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score152Pre-tax Margin (%)-20.2Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-19.1Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-12.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-28.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.6ROIC % (ttm)-29.9Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 19.58-22%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 19.58-22%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 19.58-22%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 19.58-37%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 19.58-37%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 19.58-67%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 19.5840%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 19.5811%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-36.1 view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-41.81 view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-34.99 view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-38.02 view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-35.87 view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-44.55 view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-42.04 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-55.04 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-57.62 view
Sumeray MarkChief Medical Officer 2014-03-14Sell2,000$51.34-61.86 view

Quarterly/Annual Reports about AEGR:

News about AEGR:

Articles On GuruFocus.com
Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
Three CEOs Reporting Large Insider Buys May 22 2014 
Four CEOs Reporting Large Insider Buys May 09 2014 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

More From Other Websites
What's in Store for Aegerion (AEGR) This Earnings Season? - Analyst Blog Aug 03 2015
Will Endocyte (ECYT) Earnings Surprise Investors in Q2? - Analyst Blog Aug 03 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Jul 30 2015
Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward Jul 28 2015
Aegerion Pharma upgraded by Jefferies Jul 28 2015
5 Hated Earnings Stocks You Should Love Jul 27 2015
Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth Jul 27 2015
Aegerion Pharmaceuticals Announces Leadership Changes to Support the Next Stage of Growth Jul 27 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jul 13 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jul 13 2015
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 29 2015
Notable option activity in equities Jun 29 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer Jun 25 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as CFO Jun 25 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer Jun 25 2015
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths Jun 22 2015
Aegerion Pharmaceuticals Announces Key Additions to Medical Affairs and Drug Safety Jun 16 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jun 11 2015
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jun 11 2015
Scopia Management returns an estimated 4.43% for May Jun 03 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK